Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment

Lorenza Lucidi,Mauro Pettorruso,Federica Vellante,Francesco Di Carlo,Franca Ceci,Maria Chiara Santovito,Ilenia Di Muzio,Michele Fornaro,Antonio Ventriglio,Carmine Tomasetti,Alessandro Valchera,Alessandro Gentile,Yong-Ku Kim,Giovanni Martinotti,Silvia Fraticelli,Massimo Di Giannantonio,Domenico De Berardis

DOI: https://doi.org/10.3390/ijms22073723

IF: 5.6

2021-04-02

International Journal of Molecular Sciences

Abstract:The gut microbiota is the set of microorganisms that colonize the gastrointestinal tract of living creatures, establishing a bidirectional symbiotic relationship that is essential for maintaining homeostasis, for their growth and digestive processes. Growing evidence supports its involvement in the intercommunication system between the gut and the brain, so that it is called the gut–brain–microbiota axis. It is involved in the regulation of the functions of the Central Nervous System (CNS), behavior, mood and anxiety and, therefore, its implication in the pathogenesis of neuropsychiatric disorders. In this paper, we focused on the possible correlations between the gut microbiota and Bipolar Disorder (BD), in order to determine its role in the pathogenesis and in the clinical management of BD. Current literature supports a possible relationship between the compositional alterations of the intestinal microbiota and BD. Moreover, due to its impact on psychopharmacological treatment absorption, by acting on the composition of the microbiota beneficial effects can be obtained on BD symptoms. Finally, we discussed the potential of correcting gut microbiota alteration as a novel augmentation strategy in BD. Future studies are necessary to better clarify the relevance of gut microbiota alterations as state and disease biomarkers of BD.

biochemistry & molecular biology,chemistry, multidisciplinary